Palatin Technologies, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 45210
 
 
 
C07K PEPTIDES 16120
 
 
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9700592 Uses of bremelanotide in therapy for female sexual dysfunctionMay 05, 15Jul 11, 17[A61K, A61P, C07K]
9580466 Melanocortin-1 receptor-specific linear peptidesDec 30, 14Feb 28, 17[A61K, C07K]
9458201 Melanocortin receptor-specific heptapeptidesJul 11, 14Oct 04, 16[A61K, C07K]
9447148 Melanocortin-1 receptor-specific cyclic peptidesOct 15, 14Sep 20, 16[A61K, C07K]
9352013 Uses of bremelanotide in therapy for female sexual dysfunctionJun 24, 14May 31, 16[A61K, A61P, C07K]
9273098 Lactam-bridged melanocortin receptor-specific peptidesDec 06, 11Mar 01, 16[A61K, C07K]
8933194 Melanocortin-1 receptor-specific linear peptidesMay 16, 12Jan 13, 15[A61K, C07K]
8877890 Melanocortin-1 receptor-specific cyclic peptidesJun 05, 13Nov 04, 14[A61K, A61P, C07K]
8846601 Melanocortin receptor-specific peptidesDec 06, 11Sep 30, 14[A61K, C07K]
8828926 Uses of natriuretic peptide constructsOct 17, 12Sep 09, 14[A61K, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2011/0263,818 Peptidic Constructs with Amino Acid SurrogatesAbandonedJun 17, 11Oct 27, 11[C07K]
7655658 Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compoundsExpiredJan 21, 05Feb 02, 10[A61K, C07D]
2009/0305,960 Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669AbandonedJun 08, 09Dec 10, 09[A61K, A61P, C07K]
2009/0253,713 Small Molecule Compositions for Sexual DysfunctionAbandonedJun 19, 09Oct 08, 09[A61K, C07D]
7550602 Small molecule compositions for sexual dysfunctionExpiredJan 14, 05Jun 23, 09[A01N, C07D]
2009/0081,197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of ObesityAbandonedMay 30, 08Mar 26, 09[A61K, C12Q, G01N, A61P]
2009/0076,029 Compounds and Methods for Treating ObesityAbandonedMay 30, 08Mar 19, 09[A61K, G01N, A61P]
2008/0255,033 Metallopeptide gamma-Melanocyte Stimulating Hormone CompoundsAbandonedJun 10, 08Oct 16, 08[A61K]
2008/0227,693 Cyclic Peptide Isolation by Spray DryingAbandonedAug 29, 06Sep 18, 08[A61K, C07K]
7425608 Method of making metallopeptidesExpiredSep 07, 05Sep 16, 08[C07K]
7396814 Metallopeptide compositions for treatment of sexual dysfunctionExpiredJan 14, 05Jul 08, 08[A61K]
2006/0240,481 Melanocortin Metallopeptode Combinatorial Libraries and ApplicationsAbandonedMay 22, 06Oct 26, 06[C40B]
7097824 Tuftsin metallopeptide analogs and uses thereofExpiredFeb 11, 03Aug 29, 06[A61K]
2006/0083,685 Opioid metallopeptide compositions and methodsAbandonedDec 01, 05Apr 20, 06[A61K, C40B, C07K]
2006/0040,324 Methods for making metallopeptides and metallopeptide librariesAbandonedAug 05, 05Feb 23, 06[C40B]
6979436 Opioid metallopeptide compositions and methodsExpiredMay 17, 02Dec 27, 05[A61K, A61M]
2005/0037,951 Composition and methods for treatment of sexual dysfunctionAbandonedSep 20, 04Feb 17, 05[A61K]
2002/0012,948 Metallopeptide combinatorial libraries and applicationsAbandonedJun 14, 01Jan 31, 02[G01N, C07K]
4248360 Remote control cap for a spray canExpiredSep 10, 79Feb 03, 81[B65D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.